What are the major opportunities in the Generative Artificial Intelligence (AI) In Pharmaceutical market? What are the strategies for the Generative Artificial Intelligence (AI) In Pharmaceutical market?

For detailed insights on the major opportunities and strategies in the Generative Artificial Intelligence (AI) In Pharmaceutical market, Read More

How does the Generative Artificial Intelligence (AI) In Pharmaceutical market relate to the overall economy and other similar markets?

For detailed insights on Generative Artificial Intelligence (AI) In Pharmaceutical's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Generative Artificial Intelligence (AI) In Pharmaceutical market growth? SWOT analysis of the Generative Artificial Intelligence (AI) In Pharmaceutical market.

For detailed insights on the key dynamics influencing the Generative Artificial Intelligence (AI) In Pharmaceutical market growth and SWOT analysis of the Generative Artificial Intelligence (AI) In Pharmaceutical industry, Read More

Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2025

Name: Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Small Molecule, Large Molecule), By Technology (Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies), By Application (Clinical Trial Research, Drug Discovery, Research And Development, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Generative Artificial Intelligence (AI) In Pharmaceutical Market?

Generative artificial intelligence (AI) in pharmaceuticals leverages advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and optimize Drug Discovery processes. It uses techniques such as deep learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions.

The main types of generative artificial intelligence (AI) in pharmaceuticals are small molecules and large molecules. Small-molecule drugs are low-molecular-weight compounds that can easily enter cells and affect biological processes. The various technologies include deep learning, Natural Language Processing, querying methods, context-aware processing, and others for varying applications such as clinical trial research, drug discovery, research and development, and others.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Size and growth rate 2025 to 2029: Graph

What Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Size 2025 And Growth Rate?

The generative artificial intelligence (AI) in pharmaceutical market size has grown exponentially in recent years. It will grow from $1.85 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth in the historic period can be attributed to growth in computational power, the rise of big data in healthcare and pharmaceuticals, increased research and development investment, improved data quality and integration, and expansion of cloud computing.

What Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Growth Forecast?

The generative artificial intelligence (AI) in pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $7.16 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to a focus on early disease detection, regulatory support, and guidelines, improved computational power, growth in drug development costs, increased data availability. Major trends in the forecast period include blockchain and AI integration, advanced data integration, enhanced disease diagnosis, automated drug repurposing, real-time clinical trial optimization.

Book your 30 minutes free consultation with our research experts

How Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmented?

The generative artificial intelligence (AI) in pharmaceutical market covered in this report is segmented –

1) By Type: Small Molecule, Large Molecule

2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies

3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications

Subsegments:

1) By Small Molecule: Drug Discovery And Design, Lead Optimization For Small Molecule Compounds, Predictive Modeling For Pharmacokinetics And Toxicity, Virtual Screening Of Compound Libraries, Personalized Medicine Approaches For Small Molecule Therapies

2) By Large Molecule: Biologics Discovery And Development, Monoclonal Antibody Design, Protein Engineering And Optimization, Vaccine Development And Optimization, Predictive Models For Biopharmaceutical Efficacy And Safety.

What Is Driving The Generative Artificial Intelligence (AI) In Pharmaceutical Market? Rising Emphasis On Personalized Medicine Drive Generative AI In Pharmaceutical Market

The increasing focus on personalized medicine is expected to propel the growth of generative artificial intelligence (AI) in the pharmaceutical market going forward. Personalized medicine tailors medical treatment to the individual characteristics, needs, and preferences of each patient based on genetic, environmental, and lifestyle factors. The focus on personalized medicine is increasing due to advancements in genetic research and technology, enabling more precise and effective treatments tailored to individual patients. Personalized medicine leverages generative AI in pharmaceuticals to develop tailored drug therapies, improving treatment efficacy and patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing focus on personalized medicine is driving the growth of generative artificial intelligence (AI) in the pharmaceutical market.

Who Are The Major Players In The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market?

Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited

What Are The Key Trends Of The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market? Advancements In Drug Discovery With Generative AI

Major companies operating in generative artificial intelligence (AI) in pharmaceutical market are developing new products, such as AI healthcare microservices, to streamline drug discovery processes. AI healthcare microservices are modular, cloud-based services that use artificial intelligence to improve healthcare functions such as drug discovery, medical imaging, and diagnostics. For instance, in March 2024, Nvidia Corporation, a US-based technology company, launched generative AI microservices. It features optimized NIM AI models and workflows with APIs for building cloud-native applications. It provides advanced imaging, natural language, and speech recognition, along with digital biology capabilities. The key tools included are Parabricks, MONAI, NeMo, Riva, and Metropolis are accessible as CUDA-X microservices, enhancing workflows in drug discovery and genomics.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market? Eli Lilly Collaborated With XtalPi For AI Drug Discovery

In June 2023, Eli Lilly and Company, a US-based company engaged in research-based pharmaceutical and biomedical research, collaborated with XtalPi Inc. The partnership will use XtalPi’s advanced AI-driven drug discovery platform, ID4Inno, to design and develop drug candidates targeting a specific, undisclosed goal. This collaboration aims to leverage XtalPi's technology to explore extensive chemical spaces and identify promising drug candidates through a process of iterative design, synthesis, testing, and analysis, all supported by autonomous robotic systems to ensure efficiency and precision. XtalPi Inc. is a China-based AI-powered drug research and development company.

What Is The Regional Outlook For The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market?

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2024. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative artificial intelligence (AI) in pharmaceutical market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Generative Artificial Intelligence (AI) In Pharmaceutical Market?

The generative artificial intelligence (AI) in pharmaceutical market includes revenues earned by entities through drug design, clinical trial optimization, biomarker discovery, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Generative Artificial Intelligence (AI) In Pharmaceutical Industry?

The generative artificial intelligence (AI) in pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in pharmaceutical market statistics, including generative artificial intelligence (AI) in pharmaceutical industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in pharmaceutical market share, detailed generative artificial intelligence (AI) in pharmaceutical market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in pharmaceutical industry. This generative artificial intelligence (AI) in pharmaceutical market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.43 billion
Revenue Forecast In 2034	$7.16 billion
Growth Rate	CAGR of 31.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Small Molecule, Large Molecule 2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies 3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications Subsegments: 1) By Small Molecule: Drug Discovery And Design, Lead Optimization For Small Molecule Compounds, Predictive Modeling For Pharmacokinetics And Toxicity, Virtual Screening Of Compound Libraries, Personalized Medicine Approaches For Small Molecule Therapies 2) By Large Molecule: Biologics Discovery And Development, Monoclonal Antibody Design, Protein Engineering And Optimization, Vaccine Development And Optimization, Predictive Models For Biopharmaceutical Efficacy And Safety.
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Characteristics

3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Growth Analysis And Strategic Analysis Framework

5.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Growth Rate Analysis

5.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Generative Artificial Intelligence (AI) In Pharmaceutical Total Addressable Market (TAM)

6. Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

6.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Molecule

Large Molecule

6.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deep Learning

Natural Language Processing

Querying Method

Context-Aware Processing

Other Technologies

6.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Trial Research

Drug Discovery

Research And Development

Other Applications

6.4. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Discovery And Design

Lead Optimization For Small Molecule Compounds

Predictive Modeling For Pharmacokinetics And Toxicity

Virtual Screening Of Compound Libraries

Personalized Medicine Approaches For Small Molecule Therapies

6.5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologics Discovery And Development

Monoclonal Antibody Design

Protein Engineering And Optimization

Vaccine Development And Optimization

Predictive Models For Biopharmaceutical Efficacy And Safety

7. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regional And Country Analysis

7.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market

8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative Artificial Intelligence (AI) In Pharmaceutical Market

9.1. China Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

9.2. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative Artificial Intelligence (AI) In Pharmaceutical Market

10.1. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market

11.1. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

11.2. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market

12.1. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market

13.1. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market

14.1. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

14.2. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

15.1. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

15.2. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market

16.1. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market

17.1. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative Artificial Intelligence (AI) In Pharmaceutical Market

18.1. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market

19.1. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market

20.1. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

21.1. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

21.2. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market

22.1. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market

23.1. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

23.2. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market

24.1. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

24.2. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market

25.1. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

25.2. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market

26.1. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

26.2. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market

27.1. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market

28.1. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

28.2. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market

29.1. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

29.2. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Company Profiles

30.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape

30.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Generative Artificial Intelligence (AI) In Pharmaceutical Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Sanofi S.A.

31.3. Bristol-Myers Squibb Company

31.4. AstraZeneca PLC

31.5. Novartis AG

31.6. GlaxoSmithKline plc

31.7. Fujitsu Limited

31.8. Takeda Pharmaceutical Company Limited

31.9. Eli Lilly and Company

31.10. Amgen Inc.

31.11. Gilead Sciences Inc.

31.12. NVIDIA Corporation

31.13. Conduent Incorporated

31.14. XtalPi Inc.

31.15. Insilico Medicine Inc.

32. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

34. Recent Developments In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

35. Generative Artificial Intelligence (AI) In Pharmaceutical Market High Potential Countries, Segments and Strategies

35.1 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2029 - Countries Offering Most New Opportunities

35.2 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2029 - Segments Offering Most New Opportunities

35.3 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Pfizer Inc. Financial Performance

Table 77: Johnson & Johnson Financial Performance

Table 78: Roche Holding AG Financial Performance

Table 79: Merck & Co. Inc. Financial Performance

Table 80: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Pfizer Inc. Financial Performance

Figure 77: Johnson & Johnson Financial Performance

Figure 78: Roche Holding AG Financial Performance

Figure 79: Merck & Co. Inc. Financial Performance

Figure 80: AbbVie Inc. Financial Performance

Explore growth forecasts and key drivers in the global self-learning AI and reinforcement learning market.

Explore how serverless architecture is revolutionizing the global serverless computing platforms market.

Get insights on the global Kitchen Remodel Services Market including latest trends, forecasts, and key statistics from The Business Research Company.

Get insights on the global LLMs In Cybersecurity Market including latest trends, forecasts, and key statistics from The Business Research Company.

Quantum Artificial Intelligence (AI) Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

The Future of theQuantum Chip Market: Growth Trends, Market Size, and Opportunities to Watch

Quantum Computing And Technologies Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

How the Quantum Computing as a Service (QCaaS) Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

Generative AI In Gaming Global Market Report 2025 – By Technique (Deterministic, Nondeterministic), By Function (Image Enhancement, Level Generation, Scenarios And Stories, Balancing In-Game Complexity, Non-Player Charac...

View Report

Generative AI Global Market Report 2025 – By Component (Software, Services), By Offering Type (Image, Video, Speech, Other Offering Types), By Technology (Generative Adversarial Networks (GANs), Transformer, Variational ...

View Report

Generative Artificial Intelligence (AI) in Sports Global Market Report 2025 – By Sports Type (Football, Tennis, Cricket, Basketball, Hockey, Golf, Other Sports), By Deployment (On-premises, Cloud-based), By Application (...

View Report

Generative Artificial Intelligence In Development And Operations (DevOps) Global Market Report 2025 – By Component (Solutions, Services), By Deployment Mode (On-premise, Cloud-based), By Application (Testing, Deployment,...

View Report

Artificial Intelligence (AI) In Agriculture Global Market Report 2025 – By Component (Hardware, Software, Services), By Technology (Machine Learning, Predictive Analysis, Computer Vision), By Deployment (Cloud, On-Premis...

View Report

Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025 – By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), By Indicati...

View Report

Artificial Intelligence (AI) In Video Surveillance Global Market Report 2025 – By Offering (Hardware, Software, Service), By Deployment Mode (On-Premises, Cloud-Based), By Use Cases (Gun Detection, Industrial Temperature...

View Report

Artificial Intelligence (AI) In Hospitality Global Market Report 2025 – By Technology (Machine Learning, Natural Language Processing, Chatbots Or Travel Bots, Blockchain, Big Data, Other Technologies), By Hospitality Typ...

View Report

Frequently Asked Questions

What is the definition of the Generative Artificial Intelligence (AI) In Pharmaceutical market?

Generative artificial intelligence (AI) in pharmaceuticals leverages advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and optimize drug discovery processes. It uses techniques such as deep learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions. For further insights on the Generative Artificial Intelligence (AI) In Pharmaceutical market, request a sample here

How will the Generative Artificial Intelligence (AI) In Pharmaceutical market drivers and restraints affect the market dynamics? What forces will shape the Generative Artificial Intelligence (AI) In Pharmaceutical industry going forward?

The Generative Artificial Intelligence (AI) In Pharmaceutical market major growth driver - Rising Emphasis On Personalized Medicine Drive Generative AI In Pharmaceutical Market. For further insights on the Generative Artificial Intelligence (AI) In Pharma request a sample here

What is the forecast market size or the forecast market value of the Generative Artificial Intelligence (AI) In Pharmaceutical market?

The Generative Artificial Intelligence (AI) In Pharmaceutical market size has grown strongly in recent years. The generative artificial intelligence (AI) in pharmaceutical market size has grown exponentially in recent years. It will grow from $1.85 $ billion in 2024 to $2.43 $ billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth in the historic period can be attributed to growth in computational power, the rise of big data in healthcare and pharmaceuticals, increased research and development investment, improved data quality and integration, and expansion of cloud computing. The generative artificial intelligence (AI) in pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $7.16 $ billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to a focus on early disease detection, regulatory support, and guidelines, improved computational power, growth in drug development costs, increased data availability. Major trends in the forecast period include blockchain and AI integration, advanced data integration, enhanced disease diagnosis, automated drug repurposing, real-time clinical trial optimization. For further insights on the Generative Artificial Intelligence (AI) In Pharmaceutical market, request a sample here

How is the Generative Artificial Intelligence (AI) In Pharmaceutical market segmented?

The generative artificial intelligence (AI) in pharmaceutical market covered in this report is segmented –
1) By Type: Small Molecule, Large Molecule
2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies
3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications
Subsegments:
1) By Small Molecule: Drug Discovery And Design, Lead Optimization For Small Molecule Compounds, Predictive Modeling For Pharmacokinetics And Toxicity, Virtual Screening Of Compound Libraries, Personalized Medicine Approaches For Small Molecule Therapies
2) By Large Molecule: Biologics Discovery And Development, Monoclonal Antibody Design, Protein Engineering And Optimization, Vaccine Development And Optimization, Predictive Models For Biopharmaceutical Efficacy And Safety. For further insights on the Generative Artificial Intelligence (AI) In Pharmaceutical market, request a sample here

Which region has the largest share of the Generative Artificial Intelligence (AI) In Pharmaceutical market? What are the other regions covered in the report?

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2024. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Generative Artificial Intelligence (AI) In Pharmaceutical market, request a sample here.

Who are the major players in the Generative Artificial Intelligence (AI) In Pharmaceutical market?

What are the key trends in the Generative Artificial Intelligence (AI) In Pharmaceutical market?

Major trends in the Generative Artificial Intelligence (AI) In Pharmaceutical market include Advancements In Drug Discovery With Generative AI. For further insights on the Generative Artificial Intelligence (AI) In Pharmaceutical market, request a sample here.

Book your 30 minutes free consultation with our research experts

Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2025

What Is Covered Under Generative Artificial Intelligence (AI) In Pharmaceutical Market?

What Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Size 2025 And Growth Rate?

What Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Growth Forecast?

How Is The Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmented?

What Is Driving The Generative Artificial Intelligence (AI) In Pharmaceutical Market? Rising Emphasis On Personalized Medicine Drive Generative AI In Pharmaceutical Market

Who Are The Major Players In The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market?

What Are The Key Trends Of The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market? Advancements In Drug Discovery With Generative AI

What Are Latest Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market? Eli Lilly Collaborated With XtalPi For AI Drug Discovery

What Is The Regional Outlook For The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market?

What Defines the Generative Artificial Intelligence (AI) In Pharmaceutical Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Generative Artificial Intelligence (AI) In Pharmaceutical Industry?

Generative Artificial Intelligence (AI) In Pharmaceutical Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions